Advancing genomic research will accelerate the discovery of precision therapies, improve access and health outcomes, and deliver on the potential of Human Data Science.
IQVIA links genomic data with other datasets to advance precision medicine and patient care through better prevention, earlier diagnosis, and more targeted treatment for patients.
We provide a global end-to-end solution from an innovative e-consent tool, over genomic de-identification technology right through to identifying patient cohorts for clinical trials. It is our desire to support the small group of global citizens that have a rare disease and offer them better treatment that is tailored to the individual.
Learn how IQVIA is unlocking genomic data, at scale, while preserving privacy. Enabling a faster, more flexible, and less expensive approach for scientific enquiry into human biology, drug discovery and drug development.
